Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia

Rituximab is an anti-CD20 monoclonal antibody that has been used to treat several complications of systemic lupus erythematosus (SLE) including nephritis, cerebritis, and hematological disorders. Neutropenia is among the adverse events associated with rituximab; this usually occurs several weeks aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Arroyo-Ávila, Mariangelí, Fred-Jiménez, Ruth M., Vilá, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342062/
https://www.ncbi.nlm.nih.gov/pubmed/25767732
http://dx.doi.org/10.1155/2015/616787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342062/
https://www.ncbi.nlm.nih.gov/pubmed/25767732
http://dx.doi.org/10.1155/2015/616787

Ejemplares similares